Botox, lip filler and “salmon sperm” treatments are everywhere. But what can they realistically achieve, what are the risks, and how do you choose someone you can trust? This week, Afif and Anne are joined by Dr Grace Daly, a dentist working in facial aesthetics, for a frank conversation about cosmetic treatments and the pressure to change how we look. Grace explains the differences between Botox, hyaluronic acid fillers and polynucleotides, why results don’t always match expectations, and when she tells a patient that more treatment isn’t the answer. We discuss: • Pregnancy and breastfeeding, including why evidence and clinic policies can differ• “Preventative Botox” and the pressure to start younger• Filler complications, migration and how long results can last• Teenagers, social media and conversations about changing their appearance• Checking a practitioner’s credentials and looking beyond the cheapest offer• Why a consultation should leave room for saying no There’s also Afif’s unexpected Camino tattoo, Anne’s response, and a skincare confession involving Head & Shoulders. Find Grace on Instagram: @agewithgrace_ Enjoyed the episode? Follow The Family Tribe, leave a review and share it with someone who would find this conversation useful. BT: RSV: The Injection Keeping Babies Out of Hospital RSV season is here, and Ireland’s infant RSV immunisation programme is now in its third winter. In this episode, Afif and Anne explain what RSV does to babies, why some develop bronchiolitis severe enough to need hospital care, and revisit their own experience when their 4-week-old son was admitted with RSV. They also look at nirsevimab, the long-acting antibody now used to protect babies through RSV season, and the latest evidence showing substantial reductions in RSV-related hospitalisations in both Australia and Ireland. They discuss who is eligible in Ireland, how the immunisation works, side effects, and why preventing RSV admissions matters for both families and the wider hospital system. Useful links HSE: RSV immunisation for babies Queensland nirsevimab study
